Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on June 12, 2025
Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma
GlobeNewswire
·
June 12, 2025
Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of indolent non-Hodgkin lymphoma (iNHL) $9 million from new investor The Institute for Follicular Lymphoma Innovation (IFLI) $10 million …
Amaroq lýkur vel heppnaðri hlutafjáraukningu
GlobeNewswire
·
June 12, 2025
Reykjavík, June 12, 2025 (GLOBE NEWSWIRE) -- ÞESSI TILKYNNING OG UPPLÝSINGARNAR SEM HÉR BIRTAST ERU EKKI ÆTLAÐAR TIL ÚTGÁFU, BIRTINGAR EÐA DREIFINGAR, BEINT EÐA ÓBEINT, Í HEILD EÐA AÐ HLUTA, Í EÐA TIL BANDARÍKJANNA, ÁSTRALÍU, JAPAN, LÝÐVELDISINS SUÐUR- …
Results of Fundraising
GlobeNewswire
·
June 12, 2025
Reykjavík, June 12, 2025 (GLOBE NEWSWIRE) -- THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, …
Critical One Makes Strategic Uranium Asset Divestment
GlobeNewswire
·
June 12, 2025
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that Dark Star Minerals Inc. (“Dark Star”) (CSE: BATT) (FSE: …
Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD
GlobeNewswire
·
June 12, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on continued momentum with United States Food and Drug Administration (FDA) …